Key informant interview on antimicrobial resistance (AMR) in some countries in the western pacific region

Globalization and Health

Mami Wakabayashi²  Yuri Lee¹ 

[1] Institute of Health Services Research, Yonsei University, Seoul, South Korea;Health Services Development Unit, World Health Organization, Western Pacific Regional Office, United Nations Avenue, P.O. Box 2932, Manila, 1000, Philippines

关键词: World health organization (WHO);    World health day;    Western pacific region;    Key informant interview (KII);    Antimicrobial resistance (AMR);   

Others  :  813296
DOI  :  10.1186/1744-8603-9-34

 received in 2013-01-08, accepted in 2013-06-28,  发布年份 2013

【 摘 要 】

Background

The World Health Organization (WHO) selected antimicrobial resistance (AMR) as the theme for World Health Day 2011. The slogan was “Combat Drug Resistance – No action today, no cure tomorrow” A six-point policy package was launched as a core product for World Health Day. It aimed to stimulate extensive and coherent action to overcome the many challenges presented by antimicrobial resistance.

Methods

As a preparation for World Health Day, interviews were conducted with a series of key informants, mainly senior government staff, to assess their awareness of the topic and the interventions proposed in the policy package. Since the key informant interview methodology was used with a small number of interviewees, it may be difficult to demonstrate the validity of the findings.

Results

Key informants from twelve out of fifteen countries responded, which included Fiji (n = 5), Kiribati (n = 1), Lao PDR (n = 2), Malaysia (n = 6), Micronesia (n = 3), Mongolia (n = 5), the Philippines (n = 5), Vietnam (n = 6), Vanuatu (n = 1), Solomon Islands (n = 3), Cambodia (n = 5) and Brunei (n = 1). There was a total of forty-three respondents (n = 43). AMR was widely recognized as a problem. Lack of a coherent, comprehensive and national plan or strategy was noted. Surveillance was often seen as weak and fragmented even where presented. Laboratory capacity was felt to be insufficient across all countries interviewed. The majority of respondents stressed the need for national and local plans to combat AMR including reliable estimates of the financial cost of combating and managing AMR, the need for legislation to control inappropriate use of antimicrobials in food animals and more serious efforts to promote Standard Treatment Guidelines (STGs) and Rational Prescription. Also, importance was highlighted of the need to include infection prevention and control (IPC) as a part of accreditation and registration of health institutions and programs to promote IPC to the general population.

Conclusion

A coalition of interested parties at the local, national and international levels need to generate and sustain the political will to organize a more comprehensive, sustainable, and coherent approach to AMR.

【 授权许可】

   
2013 Lee and Wakabayashi; licensee BioMed Central Ltd.

【 参考文献 】

• [1]James M, Hughes MD: Preserving the lifesaving power of antimicrobial agents. JAMA 2011, 305(10):1027-1028. Epub 2011 Feb 22
• [2]WHO Regional Office for South-East Asia: Regional strategy on prevention and containment of antimicrobial resistance 2010–2015. New Delhi, India; 2010.
• [3]World Health Organization: Fact sheet. 2011. [http://www.who.int/mediacentre/factsheets/fs194/en/ webcite]
• [4]WHO: Global strategy for containment of antimicrobial resistance. Geneva: WHO; 2001. World Health Organization. (WHO/CDS/CSR/DRS/2001.2) Available at: [http://www.who.int/entity/csr/resources/publications/drugresist/en/EGlobal_Strat.pdf webcite]
• [5]Arias CA, Murray BE: Antibiotic resistant bugs in the 21st century - A clinical super-challenge. N Engl J Med 2009, 360:439-442.
• [6]Morel C, Mossialos E: Stoking the antibiotic pipeline. BMJ 2010, 340:1115-1118.
• [7]Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD: Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010, 340:c2096.
• [8]Butler CC, Hillier S, Roberts Z, Dunstan F, Howard A, Palmer S: Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E coli UTIs. Br J Gen Pract 2006, 56:686-692.
• [9]World Health Organization: Fact sheet, Medicines: rational use of medicines. May. [http://www.who.int/mediacentre/factsheets/fs338/en/index.html webcite]
• [10]Cornaglia G, Lönnroth A, Struelens M: Report from the European conference on the role of research in combating antibiotic resistance, 2003. Clin Microbiol Infect 2004, 10:473-497.
• [11]WHO Regional Office for Western Pacific: Provisional agenda item 10. Manila, Philippines: Regional Committee sixty-second session; 2011. 10–14 October 2011
• [12]Emily L, Diana EW, Mario R, Hiroki N, on behalf of the World Health Organization World Health Day Antimicrobial Resistance Technical Working Group: The WHO policy package to combat antimicrobial resistance. Bull World Health Organ 2011, 89(5):390-392.
• [13]Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, JE D: European antimicrobial resistance surveillance system. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002, 8(3):278-282.
• [14]World Health Organization: World Health Day 2011 brochure. 2011. [http://www.who.int/world-health-day/2011/world-health-day2011-brochure.pdf webcite]
• [15]World Health Organization: Policy package to combat antimicrobial resistance. Geneva: World Health Day; 2011.
• [16]Kumar K: Program design and evaluation methodology report no.13: Conducting key informant interviews in developing countries. Agency for International Report; 1989. December 1989
• [17]Koirala KD, Thapa SD: Antibiotic resistance and the future. JAMA 2011, 305(22):2293. author reply 2293–4
• [18]Bhatia R, Narain JP: The growing challenge of antimicrobial resistance in the South-East Asia Region: are we losing the battle? Indian J Med Res 2010, 132(5):482-486.